Ferring’s Oral Budesonide for UC Treatment Up for Advisor Review on June 2

May 22, 2023
Ferring Pharmaceuticals’ oral ulcerative colitis (UC) drug containing budesonide, known as Cortiment overseas, will come up for an approval review by health ministry advisors on June 2, along with a batch of other medicines. There is no new molecular entity...read more